- Home
- FBIOP vs WOOF Comparison
FBIOP vs WOOF Comparison
Compare FBIOP & WOOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- WOOF
- Stock Information
- Founded
- FBIOP N/A
- WOOF 1965
- Country
- FBIOP United States
- WOOF United States
- Employees
- FBIOP 101
- WOOF N/A
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- WOOF Other Specialty Stores
- Sector
- FBIOP Health Care
- WOOF Consumer Discretionary
- Exchange
- FBIOP Nasdaq
- WOOF Nasdaq
- Market Cap
- FBIOP N/A
- WOOF N/A
- IPO Year
- FBIOP N/A
- WOOF 2021
- Fundamental
- Price
- FBIOP $6.74
- WOOF $3.16
- Analyst Decision
- FBIOP
- WOOF Buy
- Analyst Count
- FBIOP 0
- WOOF 9
- Target Price
- FBIOP N/A
- WOOF $4.11
- AVG Volume (30 Days)
- FBIOP N/A
- WOOF 6.0M
- Earning Date
- FBIOP N/A
- WOOF 05-21-2025
- Dividend Yield
- FBIOP N/A
- WOOF N/A
- EPS Growth
- FBIOP N/A
- WOOF N/A
- EPS
- FBIOP N/A
- WOOF N/A
- Revenue
- FBIOP N/A
- WOOF $6,116,462,000.00
- Revenue This Year
- FBIOP N/A
- WOOF $0.37
- Revenue Next Year
- FBIOP N/A
- WOOF $1.65
- P/E Ratio
- FBIOP N/A
- WOOF N/A
- Revenue Growth
- FBIOP N/A
- WOOF N/A
- 52 Week Low
- FBIOP N/A
- WOOF $1.41
- 52 Week High
- FBIOP N/A
- WOOF $6.29
- Technical
- Relative Strength Index (RSI)
- FBIOP 67.87
- WOOF 55.77
- Support Level
- FBIOP $6.00
- WOOF $2.97
- Resistance Level
- FBIOP $6.80
- WOOF $3.40
- Average True Range (ATR)
- FBIOP 0.42
- WOOF 0.26
- MACD
- FBIOP 0.16
- WOOF -0.00
- Stochastic Oscillator
- FBIOP 96.19
- WOOF 70.62
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.